Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 17 07 2022
revised: 20 09 2022
accepted: 22 09 2022
pubmed: 4 10 2022
medline: 4 3 2023
entrez: 3 10 2022
Statut: ppublish

Résumé

To identify predictors of 30-day survival in elderly patients with coronavirus disease 2019 (COVID-19). Retrospective cohort study including patients with COVID-19 aged ≥65 years hospitalized in six European sites (January 2020 to May 2021). Data on demographics, comorbidities, clinical characteristics, and outcomes were collected. A predictive score (FLAMINCOV) was developed using logistic regression. Regression coefficients were used to calculate the score. External validation was performed in a cohort including elderly patients from a major COVID-19 centre in Israel. Discrimination was evaluated using the area under the receiver operating characteristic curve (AUC) in the derivation and validation cohorts. Survival risk groups based on the score were derived and applied to the validation cohort. Among 3010 patients included in the derivation cohort, 30-day survival was 74.5% (2242/3010). The intensive care unit admission rate was 7.6% (228/3010). The model predicting survival included independent functional status (OR, 4.87; 95% CI, 3.93-6.03), a oxygen saturation to fraction of inspired oxygen (SpO The FLAMINCOV score identifying elderly with higher or lower chances of survival may allow better triage and management, including intensive care unit admission/exclusion.

Identifiants

pubmed: 36191845
pii: S1198-743X(22)00511-0
doi: 10.1016/j.cmi.2022.09.019
pmc: PMC9523947
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

379-385

Informations de copyright

Copyright © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

Giusy Tiseo (G)

Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Ili Margalit (I)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.

Marco Ripa (M)

Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.

Vanni Borghi (V)

Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.

Hefziba Green (H)

Department of Medicine A, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University of Jerusalem Jerusalem, Israel.

Virginie Prendki (V)

Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.

Niccolò Riccardi (N)

Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Yael Dishon (Y)

Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel.

Giovanni Battista Perego (GB)

IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.

Alessandro Grembiale (A)

Azienda Sanitaria Friuli Occidentale, 'Santa Maria degli Angeli' Hospital, Pordenone, Italy.

Laura Galli (L)

Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.

Marco Tinelli (M)

Istituto AuxologicoItaliano, IRCCS, San Luca Hospital, Milan, Italy.

Antonella Castagna (A)

Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.

Cristina Mussini (C)

Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.

Dafna Yahav (D)

Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel.

Mical Paul (M)

Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel.

Marco Falcone (M)

Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. Electronic address: marco.falcone@unipi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH